Results from deployments currently in operation across pharmaceutical, CDMO, and industrial biomanufacturing environments. Not demonstration conditions.
Every parameter of a running batch on one screen — live chart, phase progression, event timeline. Each recommendation can be applied, deferred, or simulated first.
Filtering, smoothing, drift correction, multivariate models. Raw and processed signals sit in one overplot, so every step stays traceable.
The whole fleet at a glance: status per reactor, open alerts, yield and fleet health in one KPI row.
Physics-informed bioprocess models grounded in established kinetics, combined with machine learning trained on continuous process data. Each prediction traces back to its biochemical basis.
Setpoint adjustment, feed strategy, and drift correction executed within defined operational bounds. The operator retains override authority at all times.
AI Process Unit →Unified monitoring across multi-reactor and multi-site deployments. Process signatures transfer with the process during technology transfer.
Model improvement propagates across deployments as anonymised pattern data. Customer process data is not shared across organisations.
The licence unit is the site — named users and connected reactors are unlimited in every tier. The full scientific capability of the platform is present in every tier; what is gated is the compliance layer, deep plant integration, and multi-site scale.
Sixty days on a single site with the full scientific platform open. For teams who want to run their own process data through it before committing to anything.
An annual licence for universities and research institutes. The complete analysis environment for teaching and non-commercial research, with API access for your own tooling.
For process development and MSAT teams working outside GMP. Adds plant connectivity, so models run against live equipment rather than exported files.
For commercial GMP manufacturing. Full plant integration, regulated operation with audit trail and validation, and model federation across every site you run.
Outside the tier ladder: full Enterprise capability, provided free of charge, time-bounded and governed by the terms of the collaboration agreement.
* R&D refers to MSAT departments of pharmaceutical companies, R&D departments of CDMOs and CROs, and biomanufacturers.
Model architectureHybrid mechanistic-ML, process-specific initialisation, cross-deployment transfer learningControl outputFeed strategy recommendations, setpoint adjustments, drift alerts, trajectory predictionsModalitiesCHO, E. coli, yeast, microbial fermentationDeploymentOn-premise edge inference with platform synchronisationRegulatoryDesigned for GMP readiness. FDA PAT framework alignment.PartnershipNVIDIA Connect Program member
